Today: 29 May 2026
Gap Shares Stall After Old Navy Trouble Hits Traders
29 May 2026
2 mins read

Gap Shares Stall After Old Navy Trouble Hits Traders

New York, May 29, 2026, 14:04 EDT

  • Gap dropped 17.6% in afternoon trading. The retailer lowered its full-year sales forecast.
  • Old Navy took its biggest hit from women’s seasonal apparel, with dresses leading declines.
  • Gap lifted its adjusted earnings outlook, though investors zeroed in on the weaker sales growth.

Gap Inc. shares dropped 17.6% to $20.60 Friday afternoon. That puts the retailer on pace for its sharpest fall in roughly a year. Traders sold as weak demand at Old Navy offset the company’s raised profit outlook.

Gap’s stock slide is in focus as the retailer’s turnaround has relied on tighter inventory, stronger marketing, and more traffic at key brands. Even though Gap lifted its earnings guidance, cutting its sales forecast put a tougher question to investors—can the company keep growing while shoppers remain picky about buying apparel?

Gap late Thursday cut its fiscal 2026 net sales outlook and now sees growth of 1% to 2%, down from its earlier expectation of 2% to 3%. Gap boosted its adjusted diluted earnings-per-share target to a range of $2.30 to $2.40, up from $2.20 to $2.35, citing expected tariff relief.

Net sales for the first quarter were up 1% to $3.5 billion. Comparable sales, which track sales at stores and channels open at least a year, increased 2%. Gross margin dropped 130 basis points to 40.5%. A basis point equals one-hundredth of a percentage point.

Gap’s namesake brand same-store sales climbed 10%, but Old Navy, its biggest chain, saw comps up just 1%. Athleta stayed soft, off 11% on comparable sales, and Banana Republic gained 2%.

Gap CEO Richard Dickson said there was “continued progress” at the company and pointed to a double-digit comparable-sales gain for the Gap brand, calling it one of its best quarters in over twenty years. At the same time, he said results across the rest of the portfolio were “varied.” PR Newswire

Dickson said on the post-earnings call that Old Navy’s problems weren’t due to weak consumers. “We are not seeing this as a consumer issue,” he said. He pointed to dresses lacking the “right fashion and value equation.” Investing.com India

Analysts had a tough take. Dana Telsey at Telsey Advisory told Reuters Gap’s “moderated outlook is disappointing,” and BTIG called Old Navy the “key swing factor.” JPMorgan moved Gap down to neutral from overweight and dropped its price target to $27 from $35. Reuters Investing.com

Gap slid harder than the broader retail group again, with pressure across mall and apparel stocks. The SPDR S&P Retail ETF lost 1.8%. American Eagle Outfitters dropped 12.7% after warning about near-term margin pressure.

Gap is still seeing a profit cushion. The company said it’s expecting around $80 million of net tariff relief to help gross profit and operating income this year, some of which will go toward higher fuel costs and potential promotions. Adjusted earnings don’t include things like a $313 million legal-settlement gain and a $50 million charitable gift.

Old Navy’s turnaround could drag out if dresses, swimwear and other seasonal lines stay weak. Gap might have to run more markdowns, putting pressure on margins while management works to back growth spending and stick to its earnings goals for the year. For now, Wall Street is focusing on the sales cut as the main takeaway.

Stock Market Today

  • Cocoa Prices Drop Amid Rising Supplies and Inventory Levels
    May 29, 2026, 2:20 PM EDT. Cocoa prices fell sharply on Monday, with July ICE NY cocoa down 4.32% and July ICE London cocoa down 3.66%, pressured by abundant supply. Inventories hit a 1.75-year high at 2.81 million bags. The Ivory Coast increased its 2025/26 cocoa delivery estimate to 2.2 million metric tons (MMT), up from 1.8-1.9 MMT. While concerns over a possible El Niño weather pattern have previously supported prices, recent data shows steady shipments and weaker consumer demand for chocolate in North America. Market analysts like StoneX have lowered global surplus forecasts for 2025/26 and 2026/27 due to potential weather risks. However, supply chain disruptions, including the Strait of Hormuz closure, add upward pressure by increasing costs. The mixed signals reflect ongoing volatility in the cocoa market.

Latest articles

Gap Shares Stall After Old Navy Trouble Hits Traders

Gap Shares Stall After Old Navy Trouble Hits Traders

29 May 2026
New York, May 29, 2026, 14:04 EDT Gap Inc. shares dropped 17.6% to $20.60 Friday afternoon. That puts the retailer on pace for its sharpest fall in roughly a year. Traders sold as weak demand at Old Navy offset the company’s raised profit outlook. Gap’s stock slide is in focus as the retailer’s turnaround has relied on tighter inventory, stronger marketing, and more traffic at key brands. Even though Gap lifted its earnings guidance, cutting its sales forecast put a tougher question to investors—can the company keep growing while shoppers remain picky about buying apparel? Gap late Thursday cut its
Replimune jumps 85% after FDA opens up third dose for skin cancer therapy

Replimune jumps 85% after FDA opens up third dose for skin cancer therapy

29 May 2026
Replimune Group shares soared 85% to $8.64 Friday after the company said it will resubmit its advanced melanoma drug RP1 to the FDA, which agreed to a priority review. The FDA had rejected the therapy in April, citing lack of a control group. Replimune plans to file again within days and will present new trial data at an oncology meeting May 30. Bristol Myers fell 0.6%, while Iovance dropped 6.5%.
Ambarella Drops 20% After AI Beat, $800 Million Hanwha Contract

Ambarella Drops 20% After AI Beat, $800 Million Hanwha Contract

29 May 2026
Ambarella shares dropped about 20% to $73.33 Friday after a modest earnings beat and news of a multi-year deal with Hanwha that could exceed $800 million. Fiscal Q1 revenue rose 16.9% to $100.4 million, with an adjusted profit of 11 cents a share. Gross margin fell year over year. The Invesco QQQ Trust and major AI chip peers traded higher or flat.
Replimune jumps 85% after FDA opens up third dose for skin cancer therapy
Previous Story

Replimune jumps 85% after FDA opens up third dose for skin cancer therapy

Go toTop